Connacht Asset Management LP Bausch Health Companies Inc. Call Options Transaction History

Connacht Asset Management LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $315,445 - $376,050	-11,500 Reduced 15.17%	64,300 $1.89 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $711,621 - $1.14 Million	-33,300 Reduced 30.52%	75,800 $2.41 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $1.67 Million - $2.3 Million	109,100 New	109,100 $2.27 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.